DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Shah NP, Rousselot P, Schiffer C. et al.
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.
Am J Hematol 2016;
91 (09) 869-874
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.